Friday, March 9, 2012

Launch of International Collaboration in Asthma, Allergy and Immunology

The reasons for the negative effects of allergies and asthma are variable, but in most countries patients with these diseases are either inadequately or improperly treated, resulting in a greater negative effect and resources expended. The awareness of these trends among politicians, other policymakers, patients, the general public, and many health care insurers outside the specialty of allergy and immunology is limited. This lack of awareness and knowledge gap has resulted in reduced resources allocated to treat and promote research for these diseases.
Recognizing a lack of consensus-driven information and general recommendations, four of the most influential allergy/immunology professional organizations have joined forces to launch the International Collaboration in Asthma, Allergy and Immunology (iCAALL). Participating in iCAALL are the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma & Immunology (ACAAI), the European Academy of Allergy and Clinical Immunology (EAACI) and the World Allergy Organization (WAO).
iCAALL is designed to collect and disseminate consensus-driven information about allergies, asthma and immunological diseases. Communicating this knowledge can positively impact diagnosis and treatment, as well as cost containment and policy decisions.
A major focus of this initiative is the production of a series of International Consensus (ICON) reports. These documents offer general recommendations based on global challenges in caring for patients with allergic and immunologic diseases.
The first ICON was dedicated to food allergies and was just published: 

No comments:

Post a Comment